Filter

Drug Accessibility

74 books found

Politics of the Pharmaceutical Industry and Access to Medicines
Politics of the Pharmaceutical Industry and Access to Medici...

by Hans Löfgren

2017 6 ed.
Illicit Medicines in the Global South
Illicit Medicines in the Global South

by Mathieu Quet

2021 5 ed.
Propiedad intelectual y acceso a medicamentos esenciales de calidad en Centroamérica
Propiedad intelectual y acceso a medicamentos esenciales de ...

by Gerson Elí Martínez

2008 3 ed.
Balancing Wealth and Health
Balancing Wealth and Health

by Rochelle Dreyfuss, César Rodríguez-Garavito

2014 3 ed.
Access to Medicine Versus Test Data Exclusivity
Access to Medicine Versus Test Data Exclusivity

by Owais H. Shaikh

2016 3 ed.
Intellectual Property and Public Health in the Developing World
Intellectual Property and Public Health in the Developing Wo...

by Monirul Azam

2016 3 ed.
Intellectual property, pharmaceuticals and public health
Intellectual property, pharmaceuticals and public health

by Kenneth C. Shadlen

2011 3 ed.
Post-Trial Access to Drugs in Developing Nations
Post-Trial Access to Drugs in Developing Nations

by Evaristus Chiedu Obi

2017 2 ed.
Adequacy of access to investigative drugs for seriously ill patients
Adequacy of access to investigative drugs for seriously ill ...

by United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

1997 1 ed.
Drug user fees
Drug user fees

by United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

2008 1 ed.
Closing the gaps in Hatch-Waxman
Closing the gaps in Hatch-Waxman

by United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

2002 1 ed.
Recent developments which may impact consumer access to, and demand for, pharmaceuticals
Recent developments which may impact consumer access to, and...

by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health

2001 1 ed.
FDA drug approval--a lengthy process that delays the availability of important new drugs
FDA drug approval--a lengthy process that delays the availab...

by United States. General Accounting Office

1980 1 ed.
Marketing of Clozaril
Marketing of Clozaril

by United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopolies, and Business Rights.

1991 1 ed.
Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages
Review of the proposed generic drug and biosimilars user fee...

by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health

2013 1 ed.
Improving predictability and transparency in DEA and FDA regulation
Improving predictability and transparency in DEA and FDA reg...

by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health

2015 1 ed.
Drug shortages
Drug shortages

by United States. Congress. Senate. Committee on Finance

2011 1 ed.
L'accès aux médicaments dans les pays en développement
L'accès aux médicaments dans les pays en développement

by Elisabeth Chamorand

2013 1 ed.
Compulsory license and "government use" to promote access to medicines
Compulsory license and "government use" to promote access to...

by Martin Khor

2014 1 ed.
The politics of the pharmaceutical industry and access to medicines
The politics of the pharmaceutical industry and access to me...

by Hans Löfgren

2013 1 ed.